http://pharmalicensing.com/rss/ Latest market and business intelligence from the leading publishers worldwide. en-us http://pharmalicensing.com/rss/ http://pharmalicensing.com/images/pharmalicensing_logo.gif 144 HAYWARD, Calif. (July 16, 2008) - HAYWARD, Calif.--(BUSINESS WIRE) -- IMPAX Laboratories Inc. today announced that all conditions of a settlement of the U.S. patent infringement litigation pertaining... http://pharmalicensing.com/redirs/news_rss//public/news/view/431745/5/impax-announces-final-settlement-of-generic-effexor-xr-patent-suit http://pharmalicensing.com/redirs/news_rss//public/news/view/431745/5/impax-announces-final-settlement-of-generic-effexor-xr-patent-suit CUMBERLAND, RI-- July 16, 2008 -- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that a new patent has been issued by the U.S. Patent and Trademark Office (USPTO)... http://pharmalicensing.com/redirs/news_rss//public/news/view/431077/5/collegium-pharmaceutical-inc-announces-u-s-patent-issued-covering-its-deterx-tm-abuse-deterrent-sustained-release-technology-patent-will-cover-lead-sustained-release-opioid-product-col-003-until-2025 http://pharmalicensing.com/redirs/news_rss//public/news/view/431077/5/collegium-pharmaceutical-inc-announces-u-s-patent-issued-covering-its-deterx-tm-abuse-deterrent-sustained-release-technology-patent-will-cover-lead-sustained-release-opioid-product-col-003-until-2025 Halifax, Nova Scotia, July 16, 2008 - MedMira Inc., ("MedMira") (TSX Venture: MIR, NASDAQ: MMIRF), a developer and marketer of rapid diagnostics, announced today that it received a Notice of... http://pharmalicensing.com/redirs/news_rss//public/news/view/431078/5/us-patent-for-rapid-test-method-and-technology-platform-awarded-to-medmira http://pharmalicensing.com/redirs/news_rss//public/news/view/431078/5/us-patent-for-rapid-test-method-and-technology-platform-awarded-to-medmira Madison, N. J., July 16, 2008 - Wyeth (NYSE:WYE) and Impax Laboratories Inc. today announced that all conditions of a settlement of the U.S. patent infringement litigation pertaining to Impax's... http://pharmalicensing.com/redirs/news_rss//public/news/view/431098/5/wyeth-and-impax-announce-final-settlement-of-effexor-xr-patent-suit http://pharmalicensing.com/redirs/news_rss//public/news/view/431098/5/wyeth-and-impax-announce-final-settlement-of-effexor-xr-patent-suit Tuebingen, July 14, 2008 - immatics biotechnologies GmbH today announced that the company has obtained European patent protection for its technology platform XPRESIDENT(TM). In addition, the company... http://pharmalicensing.com/redirs/news_rss//public/news/view/430760/5/immatics-obtains-important-u-s-and-european-patents http://pharmalicensing.com/redirs/news_rss//public/news/view/430760/5/immatics-obtains-important-u-s-and-european-patents July 11, 2008 -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) has made a commercial decision to enforce the rights granted to it under an exclusive license from Myriad Genetics Inc. to use... http://pharmalicensing.com/redirs/news_rss//public/news/view/430586/5/genetic-technologies-to-enforce-rights-to-brca-patents http://pharmalicensing.com/redirs/news_rss//public/news/view/430586/5/genetic-technologies-to-enforce-rights-to-brca-patents july 10, 2008--Advanced Materials Technology (AMT), a US manufacturer and developer of columns for HPLC (High Performance Liquid Chromatography), and the Berlin-based Capsulution NanoScience AG... http://pharmalicensing.com/redirs/news_rss//public/news/view/430735/5/advanced-materials-technology-and-capsulution-nanoscience-ag-conclude-patent-license-contract http://pharmalicensing.com/redirs/news_rss//public/news/view/430735/5/advanced-materials-technology-and-capsulution-nanoscience-ag-conclude-patent-license-contract July 10, 2008 - ProBioGen AG, a leading biotechnology company in cell engineering and production of biopharmaceuticals, has been granted patent protection for AGE1.CR, a proprietary duck cell line... http://pharmalicensing.com/redirs/news_rss//public/news/view/430512/5/patent-granted-for-probiogens-avian-cell-line-age1-cr http://pharmalicensing.com/redirs/news_rss//public/news/view/430512/5/patent-granted-for-probiogens-avian-cell-line-age1-cr HOUSTON--July 10, 2008--Power3 Medical Products, Inc. (OTCBB:PWRM - News) announced today the filing of a US Patent application for the diagnosis of multiple forms of Alzheimer's disease by... http://pharmalicensing.com/redirs/news_rss//public/news/view/430518/5/power3-medical-products-advances-the-diagnostic-capabilities-of-the-companys-alzheimers-disease-biomarkers http://pharmalicensing.com/redirs/news_rss//public/news/view/430518/5/power3-medical-products-advances-the-diagnostic-capabilities-of-the-companys-alzheimers-disease-biomarkers COLUMBIA, Md., July 10, 2008 -- Martek Biosciences (Nasdaq: MATK) announced today that life'sDHA(TM), its patented, vegetarian form of DHA, a long-chain omega-3 fatty acid essential for brain, eye... http://pharmalicensing.com/redirs/news_rss//public/news/view/430522/5/marteks-lifesdha-tm-featured-in-four-new-products-from-spectrum-organics http://pharmalicensing.com/redirs/news_rss//public/news/view/430522/5/marteks-lifesdha-tm-featured-in-four-new-products-from-spectrum-organics